Marius N. Stan, M.D.
Marius N. Stan, M.D., is primarily working in the area of autoimmune thyroid diseases, with a specific interest in Graves' disease and Graves' ophthalmopathy. A second area of interest is centered around drugs that alter thyroid function, mainly the thyroid excess caused by amiodarone (amiodarone-induced thyrotoxicosis).
Dr. Stan's research aims to identify novel treatments as well as methods of prevention for these conditions. He is involved in both retrospective reviews of cases and clinical trials.
Significance to patient care
Dr. Stan's research aims to improve patients' quality of life after therapy with radioactive iodine for Graves' disease. He and his colleagues also hope to offer patients more treatment options for Graves' ophthalmopathy, which is currently a condition without good therapy options.
The research into amiodarone-induce thyrotoxicosis will make patients and their doctors better equipped at defining this risk when using amiodarone. With regard to hypoparathyroidism, patients with this condition might be able to eliminate their symptoms of low calcium and leave the hospital sooner if the treatment being studied by Dr. Stan and his team turns out to be effective.
Translational Science Postdoctoral Master's Degree
Endocrinology, Diabetes, Metabolism and Nutrition
Mathematics and Physics
© 2013 Mayo Foundation for Medical Education and Research. All rights reserved.